Current directions in the treatment of hypochondriasis

Journal of Cognitive Psychotherapy

Volumn 19, Issue 3, 2005, Pages 285-304

  Taylor, Steven ^a   Asmundson, Gordon J G ^b   Coons, Michael J ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF REGINA   (Canada)

^c UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Cognitive behavior therapy; Health anxiety; Hypochondriasis; Meta analysis

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; NEFAZODONE; PAROXETINE; PLACEBO; PSYCHOTROPIC AGENT;

ADULT; ANXIETY; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPNOSIS; HYPOCHONDRIASIS; MALE; META ANALYSIS; PATIENT EDUCATION; PSYCHODYNAMICS; REVIEW; SYSTEMATIC REVIEW;

EID: 25844505113     PISSN: 08898391     EISSN: None     Source Type: Journal    
DOI: 10.1891/jcop.2005.19.3.285     Document Type: Review

References (74)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.
2. Asmundson, G. J. G., Taylor, S., & Cox, B. J. (2001). Health anxiety: Clinical and research perspectives on hypochondriasis and related conditions. New York: Wiley.
3. Avia, M. D., Ruiz, M. A., Olivares, M. E., Crespo, M., Guisado, A. B., Sanchez, A., et al. (1996). The meaning of psychological symptoms: Effectiveness of a group intervention with hypochondriacal patients. Behaviour Research and Therapy, 34, 23-31.
4. Barsky, A. J. (1996). Hypochondriasis: Medical management and psychiatric treatment. Psychosomatics, 37, 48-56.
5. Barsky, A. J. (2001). The patient with hypochondriasis. New England Journal of Medicine, 345, 1395-1399.
6. Barsky, A. J., Fama, J. M., Bailey, E. D., & Ahern, D. K. (1998). A prospective 4- to 5-year study of DSM-III-R hypochondriasis. Archives of General Psychiatry, 55, 737-744.
7. Ben-Tovim, D. I., & Esterman, A. (1998). Zero progress with hypochondriasis. Lancet, 352, 1798-1799.
8. Bernstein, I. C., Callahan, W. A., & Jaranson, J. M. (1975). Lobotomy in private practice: Long-term follow-up. Archives of General Psychiatry, 32, 1041-1047.
9. Bouman, T. K. (2002). A community-based psychoeducational group approach to hypochondriasis. Psychotherapy and Psychosomatics, 71, 326-332.
10. Bouman, T. K., & Visser, S. (1998). Cognitive and behavioural treatment of hypochondriasis. Psychotherapy and Psychosomatics, 67, 214-221.
11. Clark, D. M., Salkovskis, P. M., Hackmann, A., Wells, A., Fennell, M., Ludgate, J., et al. (1998). Two psychological treatments for hypochondriasis: A randomised controlled trial. British Journal of Psychiatry, 173, 218-225.
12. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum.
13. Deiker, T., & Counts, D. K. (1980). Hypnotic paradigm-substitution therapy in a case of hypochondriasis. American Journal of Clinical Hypnosis, 23, 122-127.
14. Devine, E. C. (1992). Effects of psychoeducational care for adult surgical patients: A meta-analysis of 191 studies. Patient Education and Counselling, 19, 129-142.
15. Enns, M. W., Kjernisted, K., & Lander, M. (2001). Pharmacological management of hypochondriasis and related disorders. In G. J. G. Asmundson, S. Taylor, & B. J. Cox (Eds.), Health anxiety: Clinical and research perspectives on hypochondriasis and related conditions (pp. 193-219). New York: Wiley.
16. Fallon, B. A. (1999). Somatoform disorders. In R. E. Feinstein & A. A. Brewer (Eds.), Primary care psychiatry and behavioral medicine: Brief office treatment and management pathways (pp. 146-170). New York: Springer.
17. Fallon, B. A. (2001). Pharmacologic strategies for hypochondriasis. In V. Starcevic & D. R. Lipsett (Eds.), Hypochondriasis: Modern perspectives on an ancient malady (pp. 329-351). New York: Oxford University Press.
18. Fallon, B. A., Javitch, J. A., Hollander, E., & Liebowitz, M. R. (1991). Hypochondriasis and obsessive compulsive disorder: Overlaps in diagnosis and treatment. Journal of Clinical Psychiatry, 52, 457-460.
19. Fallon, B. A., Liebowitz, M. R., Salman, E., Schneier, F. R., Insino, C., Hollander, E., et al. (1993). Fluoxetine for hypochondriacal patients without major depression. Journal of Clinical Psychopharmacology, 13, 438-441.
20. Fallon, B. A., Schneier, F. R., Marshall, R., Campeas, R., Vermes, D., Goetz, D., et al. (1996). The pharmacotherapy of hypochondriasis. Psychopharmacology Bulletin, 32, 607-611.
21. Fava, G. A., Grandi, S., Rafanelli, C., Fabbri, S., & Cazzaro, M. (2000). Explanatory therapy in hypochondriasis. Journal of Clinical Psychiatry, 61, 317-322.
22. Fava, M., Bless, E., Otto, M. W., Pava, J. A., & Rosenbaum, J. F. (1994). Dysfunctional attitudes in major depression: Changes with pharmacotherapy. Journal of Nervous and Mental Disease, 182, 45-49.
23. Fedoroff, I. C., & Taylor, S. (2001). Psychological and pharmacological treatments of social phobia: A meta-analysis. Journal of Clinical Psychopharmacology, 21, 311-324.
24. Furer, P., Walker, J. R., & Freeston, M. H. (2001). Integrated approach to cognitive-behavioral therapy for intense illness worries. In G. J. G. Asmundson, S. Taylor, & B. J. Cox (Eds.), Health anxiety: Clinical and research perspectives on hypochondriasis and related conditions (pp. 161-192). New York: Wiley.
25. Goldstein, S. E., & Birnbom, F. (1976). Hypochondriasis and the elderly. Journal of the American Geriatrics Society, 24, 150-154.
26. Greenblatt, M. (1959). Relation between history, personality and family pattern and behavioral responses after frontal lobe surgery. American Journal of Psychiatry, 116, 193-202.
27. House, A. (1989). Hypochondriasis and related disorders: Assessment and management of patients referred for a psychiatric opinion. General Hospital Psychiatry, 11, 156-165.
28. Kamlana, S. H., & Gray, P. (1988). Fear of AIDS. British Journal of Psychiatry, 15, 1291.
29. Keeley, R., Smith, M., & Miller, J. (2000). Somatoform symptoms and treatment nonadherence in depressed family medicine outpatients. Archives of Family Medicine, 9, 46-54.
30. Kellner, R. (1979). Psychotherapeutic strategies in the treatment of psychophysiologic disorders. Psychotherapy and Psychosomatics, 32(Suppl. 4), 91-100.
31. Kellner, R. (1982). Psychotherapeutic strategies in hypochondriasis: A clinical study. American Journal of Psychotherapy, 36, 146-157.
32. Kellner, R. (1986). Somatization and hypochondriasis. New York: Praeger.
33. Kellner, R., Pathak, D., Romanik, R., & Winslow, W. W. (1983). Life events and hypochondriacal concerns. Psychiatric Medicine, 1, 133-141.
34. Kenyon, F. E. (1964). Hypochondriasis: A clinical study. British Journal of Psychiatry, 110, 478-488.
35. Kjernisted, K. D., Enns, M. W., & Lander, M. (2002). An open-label clinical trial of nefazodone in hypochondriasis. Psychosomatics, 43, 290-294.
36. Knight, R. O. (1941). Evaluation of the results of psychoanalytic therapy. American Journal of Psychiatry, 98, 434-446.
37. Ladee, G. A. (1966). Hypochondriacal syndromes. Amsterdam: Elsevier.
38. Leonhard, K. (1961). On the treatment of ideohypochondriac and sensohypochondriac neuroses. International Journal of Social Psychiatry, 7, 123-133.
39. Lesse, S. (1967). Hypochondriasis and psychosomatic disorders masking depression. American Journal of Psychotherapy, 21, 607-620.
40. Lidbeck, J. (1997). Group therapy for somatization disorders in general practice: Effectiveness of a short cognitive-behavioural treatment model. Acta Psychiatrica Scandinavica, 96, 14-24.
41. Lippert, G. P. (1986). Excessive concern about AIDS in two bisexual men. Canadian Journal of Psychiatry, 31, 63-65.
42. Logsdail, S., Lovell, K., Warwick, H., & Marks, I. (1991). Behavioural treatment of AIDS-focused illness phobia. British Journal of Psychiatry, 159, 422-425.
43. Logsdon, C. D., & Hyer, L. (1999). Treating hypochondria in later life: Personality and health factors. In M. Duffy (Ed.), Handbook of counseling and psychotherapy with older adults (pp. 414-435). New York: Wiley.
44. Miller, D., Acton, T. M. G., & Hedge, B. (1988). The worried well: Their identification and management. Journal of the Royal College of Physicians of London, 22, 158-165.
45. Noyes, R., Kathol, R. G., Fisher, M. M., Phillips, B. M., Suelzer, M., & Woodman, C. L. (1994). One-year follow-up of medical outpatients with hypochondriasis. Psychosomatics, 35, 533-545.
46. Oltmanns, T. F., Emery, R. E., & Taylor, S. (2002). Abnormal psychology. Toronto, Canada: Prentice-Hall.
47. Oosterbaan, D. B., van Balkom, A. J. L. M., van Boeijen, C. A., de Meij, T. G. J., & van Dyck, R. (2001). An open study of paroxetine in hypochondriasis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 1023-1033.
48. Pilowsky, I. (1968). The response to treatment in hypochondriacal disorders. Australian and New Zealand Journal of Psychiatry, 2, 88-94.
49. Romanik, R. L., & Kellner, R. (1985). Case study: Treatment of herpes genitalis phobia and agoraphobia with panic attacks. Psychotherapy, 22, 542-546.
50. Salkovskis, P. M., & Warwick, H. M. (1986). Morbid preoccupations, health anxiety and reassurance: A cognitive-behavioural approach to hypochondriasis. Behaviour Research and Therapy, 24, 597-602.
51. Simons, A. D., Garfield, S. L., & Murphy, G. E. (1984). The process of change in cognitive therapy and pharmacotherapy for depression: Changes in mood and cognition. Archives of General Psychiatry, 41, 45-51.
52. Slavney, P. R. (1987). The hypochondriacal patient and Murphy's "law." General Hospital Psychiatry, 9, 302-303.
53. Snyder, A. G., & Stanley, M. A. (2001). Hypochondriasis and health anxiety in the elderly. In G. J. G. Asmundson, S. Taylor, & B. J. Cox (Eds.), Health anxiety: Clinical and research perspectives on hypochondriasis and related conditions (pp. 246-274). New York: Wiley.
54. Speckens, A. E. M., Spinhoven, P., van Hemert, A. M., Bolk, J. H., & Hawton, K. E. (1997). Cognitive behavioural therapy for unexplained physical symptoms: Process and prognostic factors. Behavioural and Cognitive Psychotherapy, 25, 291-294.
55. Speckens, A. E. M., van Hemert, A. M., Spinhoven, P., Hawton, K., Bolk, J. H., & Rooijmans, H. G. M. (1995). Cognitive behavioural therapy for medically unexplained physical symptoms: A randomized controlled trial. British Medical Journal, 311, 1328-1332.
56. Starcevic, V. (2001). Reassurance in the treatment of hypochondriasis. In V. Starcevic & D. R. Lipsett (Eds.), Hypochondriasis: Modern perspectives on an ancient malady (pp. 291-313). New York: Oxford University Press.
57. Stern, R., & Fernandez, M. (1991). Group cognitive and behavioural treatment for hypochondriasis. British Medical Journal, 303, 1229-1231.
58. Stone, A. B. (1993). Treatment of hypochondriasis with clomipramine. Journal of Clinical Psychiatry, 54, 200-201.
59. Taylor, S. (1995). Assessment of obsessions and compulsions: Reliability, validity, and sensitivity to treatment effects. Clinical Psychology Review, 15, 261-296.
60. Taylor, S. (2000). Understanding and treating panic disorder. New York: Wiley.
61. Taylor, S., & Asmundson, G. J. G. (2004). Treating health anxiety: A cognitive-behavioral approach. New York: Guilford.
62. Tyrer, P., Seivewright, N., & Behr, G. (1999). A specific treatment for hypochondriasis? Lancet, 353, 672-673.
63. van Etten, M., & Taylor, S. (1998). Comparative efficacy of treatments for posttraumatic stress disorder: A meta-analysis. Clinical Psychology and Psychotherapy, 5, 126-145.
64. Visser, S., & Bouman, T. K. (1992). Cognitive-behavioural approaches in the treatment of hypochondriasis: Six single case cross-over studies. Behaviour Research and Therapy, 30, 301-306.
65. Visser, S., & Bouman, T. K. (2001). The treatment of hypochondriasis: Exposure plus response prevention vs. cognitive therapy. Behaviour Research and Therapy, 39, 423-442.
66. Viswanathan, R., & Paradis, C. (1991). Treatment of cancer phobia with fluoxetine. American Journal of Psychiatry, 148, 1090.
67. Walker, J., Vincent, N., Furer, P., Cox, B., & Kjernisted, K. (1999). Treatment preference in hypochondriasis. Journal of Behavior Therapy and Experimental Psychiatry, 30, 251-258.
68. Warwick, H. M., & Marks, I. M. (1988). Behavioural treatment of illness phobia and hypochondriasis: A pilot study of 17 cases. British Journal of Psychiatry, 152, 239-241.
69. Warwick, H. M. C., Clark, D. M., Cobb, A. M., & Salkovskis, P. M. (1996). A controlled-trial of cognitive-behavioural treatment of hypochondriasis. British Journal of Psychiatry, 169, 189-195.
70. Warwick, H. M., & Salkovskis, P. M. (1985). Reassurance. British Medical Journal, 290, 1028.
71. Warwick, H. M. C., & Salkovskis, P. M. (2001). Cognitive-behavioral treatment of hypochondriasis. In V. Starcevic & D. R. Lipsitt (Eds.), Hypochondriasis: Modern perspectives on an ancient malady (pp. 314-328). New York: Oxford University Press.
72. Wesner, R. B., & Noyes, R. (1991). Imipramine: An effective treatment for illness phobia. Journal of Affective Disorders, 22, 43-48.
73. Williamson, P. N. (1984). An intervention for hypochondriacal complaints. Clinical Gerontologist, 3, 64-68.
74. Wooley, S. C., Blackwell, B., & Winget, C. (1978). A learning theory model of chronic illness behavior: Theory, treatment, and research. Psychosomatic Medicine, 40, 379-401.